Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Julia Katharina Schwarze actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Onderzoeksoutput
-
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors
Vounckx, M., Tijtgat, J., Stevens, L., Dirven, I., Ilsen, B., Vandenbroucke, F., Raeymaeckers, S., Vekens, K., Forsyth, R., Geeraerts, X., Van Riet, I., Schwarze, J. K., Tuyaerts, S., Decoster, L., De Ridder, M., Dufait, I. & Neyns, B., 2 jul 2024, In: Cancer Immunol Immunother. 73, 9, 8 blz., 167.Onderzoeksoutput: Article › peer review
Open AccessBestand -
Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
Taylor, A. M., McKeown, J., Dimitriou, F., Jacques, S. K., Zimmer, L., Allayous, C., Yeoh, H-L., Haydon, A., Ressler, J. M., Galea, C., Woodford, R., Kahler, K., Hauschild, A., Festino, L., Hoeller, C., Schwarze, J. K., Neyns, B., Wicky, A., Michielin, O., Placzke, J. & 9 anderen, , mrt 2024, In: European Journal of Cancer. 199, 6 blz., 113561.Onderzoeksoutput: Article › peer review
Open Access3 Citaten (Scopus) -
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-Guided Analysis
Arrieta, V. A., Duerinck, J., Burdett, K. B., Habashy, K. J., Geens, W., Gould, A., Schwarze, J. K., Dmello, C., Kim, K-S., Saganty, R., Chen, L., Moscona, A., McCord, M., Lee-Chang, C., Horbinski, C. M., Zhang, H., Stupp, R., Neyns, B. & Sonabend, A. M., 15 jan 2024, In: Clinical Cancer Research. 30, 2, blz. 379-388 10 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand6 Citaten (Scopus)133 Downloads (Pure) -
Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition
Geens, W., Vanlaer, N., Nijland, L., Van Laere, S., Schwarze, J. K., Bruneau, M., Neyns, B., Rogiers, A. & Duerinck, J., 2024, In: Journal of Neuro-Oncology. 168, 1, blz. 159-169 11 blz.Onderzoeksoutput: Article › peer review
-
Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma
Tijtgat, J., Geeraerts, X., Boisson, A., Stevens, L., Vounckx, M., Dirven, I., Schwarze, J. K., Raeymaeckers, S., Forsyth, R., Van Riet, I., Tuyaerts, S., Willard-Gallo, K. & Neyns, B., 11 jan 2024, In: Journal for ImmunoTherapy of Cancer. 12, 1, 12 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand1 Citaat (Scopus)1 Downloads (Pure)
Prijzen
-
Best Poster Award
Awada, Gil (Recipient), Özdemir, Ibrahim (Recipient), Schwarze, Julia Katharina (Recipient), Daeninck, Emma (Recipient), Gondry, Odrade (Recipient), Jansen, Y. (Recipient), Seremet, T. (Recipient), Keyaerts, Marleen (Recipient), Everaert, Hendrik (Recipient) & Neyns, Bart (Recipient), 15 dec 2018
Prijs: Prize (including medals and awards)
-
Oral presentation 3rd prize
Schwarze, Julia Katharina (Recipient), 7 feb 2020
Prijs: Prize (including medals and awards)
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor) & Bart Neyns (Contributor)
26 mrt 2022Activiteit: Talk or presentation at a conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)
26 mrt 2022Activiteit: Talk or presentation at a conference
-
Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent glioblastoma.
Wietse Geens (Speaker), Stephanie Du Four (Contributor), S VAN LAERE (Contributor), Julia Katharina Schwarze (Contributor), Gil Awada (Contributor), Michaël Bruneau (Contributor), Jens Tijtgat (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)
26 mrt 2022Activiteit: Talk or presentation at a conference
-
962MO A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells (myDC) in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
Julia Katharina Schwarze (Speaker)
17 sep 2021Activiteit: Talk or presentation at a conference
-
A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+ / CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
Julia Katharina Schwarze (Presenter), Jens Tijtgat (Contributor), Gil Awada (Contributor), Louise Cras (Contributor), Inès Dufait (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor) & Bart Neyns (Contributor)
17 sep 2021Activiteit: Talk or presentation at a conference